1
|
Munabi IG, Kamulegeya A, Kateete DP, Semitala F, Kalungi S, Cameron JE, Patton LL, Divaris K, Buwembo W. Changes in Oral Papilloma Virus Infections Over Six Months in People Living with HIV. RESEARCH SQUARE 2025:rs.3.rs-6495161. [PMID: 40313758 PMCID: PMC12045371 DOI: 10.21203/rs.3.rs-6495161/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 05/03/2025]
Abstract
There is a paucity of data on changes in oral papilloma virus (PV) infection in people living with HIV (PLHIV) especially in low resource settings. The objective of this study was to determine the changes in oral PV infections in PLHIV from a low resource setting over a six-month follow-up period. This was a cohort study in which data was derived from a sub-sample of a parent study that examined oral human papilloma viruses, microbiota, and cancer in PLWHIV. This as a six-month follow up and a 2 mls saliva sample was collected from 541 participants on both visits. The saliva sample was used for DNA extraction, PV screening and typing using PCR methods. The DNA was subjected to Nanopore PV sequencing and subsequently analyzed using the phyloseq object, followed by a series of comparisons using the Phyloseq and Vegan packages in R to generate the alpha and beta diversity indices of the sequencing data from the sampled participants PV OTUs at the two visits. We found that 60% of participants had no detectable PVs at six-month follow-up, with a significant clearance rate of 84.47%. Oncogenic PVs were less likely to be detected as new infections compared to non-oncogenic PVs (Rate Ratio (RR) 0.42, 95% CI 0.31 to 0.56, P < 0.01). Oncogenic PV types were more likely cleared than non-oncogenic strains (RR 1.16, 95% CI 1.03 to 1.31, P = 0.02), but persistence rates did not significantly differ. This study highlights important trends in the natural course of oral PV infections, demonstrating that while most infections clear over time, there are distinct differences in the behavior of oncogenic versus non-oncogenic strains. These findings have important implications for the understanding of PV epidemiology and may guide future preventive and therapeutic strategies, particularly in the context of Human PV-related cancer prevention.
Collapse
Affiliation(s)
- Ian G Munabi
- Department of Dentistry, School of Dentistry, Makerere University College of Health Sciences, Kampala, Uganda
| | - Adriane Kamulegeya
- Department of Oral and Maxillofacial surgery, School of Dentistry, Makerere University College of Health Sciences, Kampala, Uganda
| | - David P Kateete
- Department of Immunology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Fred Semitala
- Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | - Samuel Kalungi
- Department of Pathology, Mulago National Referral and Teaching Hospital, Kampala, Uganda of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | | | - Lauren L Patton
- Department of Craniofacial and Surgical Care, Adams School of Dentistry, University of North Carolina Chapel Hill, North Carolina, USA. f Pediatric Dentistry and Dental Public Health, Adams School of Dentistry, University of North Carolina Chapel Hill, North Carolina, USA
| | - Kimon Divaris
- Department of Pediatric Dentistry and Dental Public Health, Adams School of Dentistry, University of North Carolina Chapel Hill, North Carolina, USA., Department of Pediatric Dentistry and Dental Public Health, Adams School of Dentistry, University of North Carolina Chapel Hill, North Carolina, USA.Gillings School of Global Public Health, University of North Carolina Chapel Hill, North Carolina, USA
| | - William Buwembo
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| |
Collapse
|
2
|
Munabi IG, Kamulegeya A, Kalanzi D, Kateete DP, Semitala FC, Mwesigwa CL, Kalungi S, Cameron JE, Divaris K, Buwembo W. Prevalence of Oral Human Papilloma virus infection in an East African HIV/AIDS cohort: A cross-sectional study. RESEARCH SQUARE 2025:rs.3.rs-5594024. [PMID: 40313739 PMCID: PMC12045358 DOI: 10.21203/rs.3.rs-5594024/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Indexed: 05/03/2025]
Abstract
Background Little is known about the prevalence of Oral Human Papilloma Virus (OHPV) in people living with HIV (PLWHIV) in the East African region. The objective of this study was to document the prevalence and types OHPV infection in a large cohort of PLWHIV attending an urban HIV clinic in Eastern Africa. Methods This was a cross-sectional study among 1,715 participants of the Makerere University Joint AIDS Program clinic, located in Kampala, Uganda, in East Africa. A salivary sample was collected from which DNA was extracted and subjected to a Polymerase Chain Reaction (PCR) based typing. Data analysis was carried out among participants with complete data (n = 1,243) and relied on descriptive statistics (frequencies, percentages), bivariate testing and multivariate regression modeling, using a conventional p < 0.05 statistical significance threshold. Results Participants had a mean age of 45 (SD = 10) years, most (69%) were female, and 67% were HPV positive. There was no association between participants' age or gender and the likelihood of them being diagnosed with HPV infection in this study. HPV type 45 was the most frequently (16%) identified HPV, while HPV type 18 (5%) and HPV type 16 (2.3%) were less frequently identified. Most of the HPV positive samples had more than one HPV type detected. Conclusion This study highlights the high prevalence of OHPV among PLWHIV, with HPV type 45 being the most frequently detected type, and smaller frequencies of vaccine targeted HPV 16 and HPV 18. Our findings highlight the need for continued surveillance and typing of circulating OHPV strains, particularly among PLWHIV, to inform evidence-based preventive strategies.
Collapse
Affiliation(s)
- Ian G Munabi
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala
| | - Adriane Kamulegeya
- School of Dentistry, Makerere University College of Health Sciences, Kampala
| | - Dunstan Kalanzi
- School of Dentistry, Makerere University College of Health Sciences, Kampala
| | - David P Kateete
- Department of Immunology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala
| | - Fred Collins Semitala
- Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala
| | | | - Samuel Kalungi
- Department of Pathology, Mulago National Referral and Teaching Hospital, Kampala
| | | | - Kimon Divaris
- Adams School of Dentistry, University of North Carolina at Chapel Hill
| | - William Buwembo
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala
| |
Collapse
|
3
|
Morhason-Bello I, Kim K, Bello Y, Zheng Y, Oyerinde S, Idowu OC, Pavón MÁ, Baisley K, Wang J, Fowotade A, Maiga M, Jonah M, Christian EN, Ogunbiyi O, Adewole I, Hou L, Francis SC, Watson-Jones D. Assessment of Relative Contributions of Lifestyle, Behavioral and Biological Risk Factors for Cervical Human Papillomavirus Infections in Female Sex Workers. Viruses 2025; 17:485. [PMID: 40284928 PMCID: PMC12030798 DOI: 10.3390/v17040485] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2025] [Revised: 03/21/2025] [Accepted: 03/21/2025] [Indexed: 04/29/2025] Open
Abstract
This study aimed to identify and quantify the relative and collective contributions of lifestyle, behavioral, and biological risk factors to cervical HPV infections among female sex workers (FSWs) in Ibadan, Nigeria. This cross-sectional study was part of the Sexual Behavior and HPV Infections in Nigerians in Ibadan project and involved 182 FSWs for whom complete data on HPV genotypes were available. Quantile-based g-computation was employed to assess the relative and collective contributions of risk factors to any cervical HPV/hrHPV infections and multiple cervical HPV/hrHPV. The collective contribution of all selected risk factors to multiple high-risk cervical HPV was 2.47 (95% CI: 0.97-3.23). The number of other anatomic sites with HPV infections showed the highest positive relative contribution to multiple cervical HPV/hrHPV. Alcohol consumption and the total number of sexual partners contributed to high-risk cervical HPV and multiple cervical HPV/hrHPV, while age at first vaginal sex had a negative relative contribution. This study highlights the significant contribution of HPV infections in multiple anatomic sites as a risk to the acquisition of cervical HPV in FSWs. Routine screening protocols should be enhanced to include multiple anatomic sites, and targeted educational programs are recommended to address the specific risks faced by FSWs.
Collapse
Affiliation(s)
- Imran Morhason-Bello
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan/University College Hospital, Ibadan 200285, Nigeria; (S.O.); (O.C.I.)
- Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria;
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
| | - Kyeezu Kim
- Department of Social and Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon-si 16419, Republic of Korea;
| | - Yusuf Bello
- Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria;
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
| | - Yinan Zheng
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; (Y.Z.); (J.W.); (M.M.); (L.H.)
- Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;
| | - Sunday Oyerinde
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan/University College Hospital, Ibadan 200285, Nigeria; (S.O.); (O.C.I.)
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
| | - Oluwasegun Caleb Idowu
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan/University College Hospital, Ibadan 200285, Nigeria; (S.O.); (O.C.I.)
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
| | - Miquel Ángel Pavón
- Infection and Cancer Laboratory, Cancer Epidemiology Research Program, ICO, Bellvitge Biomedical Research Institute (IDIBELL), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), 08908 Barcelona, Spain;
| | - Kathy Baisley
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK;
| | - Jun Wang
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; (Y.Z.); (J.W.); (M.M.); (L.H.)
| | - Adeola Fowotade
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
- Department of Medical Microbiology, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria
| | - Mamoudou Maiga
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; (Y.Z.); (J.W.); (M.M.); (L.H.)
- Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;
| | - Musa Jonah
- Department of Obstetrics and Gynecology, Faculty of Clinical Sciences, College of Health Sciences, University of Jos, Jos 930105, Nigeria;
| | - Elizabeth Nicole Christian
- Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;
| | - Olufemi Ogunbiyi
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
- Department of Pathology, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria
| | - Isaac Adewole
- HPV Consortium, College of Medicine, University of Ibadan, Ibadan 200285, Nigeria; (A.F.); (O.O.); (I.A.)
| | - Lifang Hou
- Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; (Y.Z.); (J.W.); (M.M.); (L.H.)
- Robert J. Havey, MD Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA;
| | - Suzanna C. Francis
- International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK;
| | - Deborah Watson-Jones
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK;
- Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza P.O. Box 1462, Tanzania
| |
Collapse
|
4
|
Nwaozuru U, Obiezu-Umeh C, Uzodufa SA, Salako A, Akinsolu FT, Ezechi OC, Gbajabiamila T, Nwaokorie F, Alade OT, Eleje GU, Lusher J, Foláyan MNO. Systematic review and meta-analysis of the prevalence of oral cancer in Nigeria. BMC Oral Health 2025; 25:414. [PMID: 40119365 PMCID: PMC11927334 DOI: 10.1186/s12903-025-05724-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2024] [Accepted: 02/25/2025] [Indexed: 03/24/2025] Open
Abstract
INTRODUCTION Oral cancer is ranked among the ten most common cancers in the world and is a growing public health concern in Nigeria. However, the extent of the burden of oral cancer in Nigeria is poorly understood. A better understanding of the prevalence of oral cancer will inform the development and implementation of efficient and effective oral cancer prevention and management strategies. This systematic review and meta-analysis aimed to estimate the prevalence of oral cancer in Nigeria to guide relevant oral health interventions and policies. METHODS We searched PubMed, Embase, Scopus, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and Web of Science for studies published from 1990 until August 15, 2023. We included cohort, cross-sectional, case-control, descriptive, and interventional studies that reported prevalence data for oral cancer in Nigeria. The primary outcome was the pooled prevalence of oral cancer. Meta-analysis was performed using the random effect model. The Higgins inconsistency index -I2 index was used to evaluate heterogeneity. The quality of the studies was assessed using the Joanna Briggs Institute Critical Appraisal Checklist. RESULTS In total, 3025 articles were screened, and data from 7 studies with a total sample size of 9188 (1702 oral cancer cases) were included in the meta-analysis. Participants age ranged from 0 to 100 years. Oral cancer prevalence varied across the studies, ranging from 7.5% to 41%. The pooled prevalence of oral cancer in Nigeria was 20% (95% confidence interval, CI:0.11-0.28, I2 = 99%, P < 0.0001). An estimate of the total variation between studies revealed substantial heterogeneity (I2 = 99%). The prevalence rate differed between gender populations, with more predilection to males (11%) than females (7%). CONCLUSIONS The current analysis indicates an overall pooled oral cancer prevalence of 20% in Nigeria. The high burden of oral cancer in Nigeria highlights a need for public health interventions and policies to promote the prevention and early detection of oral cancer. The analysis also shows a higher prevalence of oral cancer among men. Population-based studies are necessary to better understand individual differences in oral cancer.
Collapse
Affiliation(s)
- Ucheoma Nwaozuru
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria.
- Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
- Department of Implementation Science, Division of Public Health Sciences, Medical Center Boulevard, 525@Vine Room 4305, NC, Winston-Salem, 27157, USA.
| | - Chisom Obiezu-Umeh
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Feinberg School of Medicine, Northwestern University, Illinois, USA
| | | | - Abideen Salako
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
| | - Folahanmi Tomiwa Akinsolu
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Department of Public Health, Lead City University, Ibadan, Nigeria
- Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Oliver Chukwujekwu Ezechi
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Department of Public Health, Lead City University, Ibadan, Nigeria
- Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Titilola Gbajabiamila
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Clinical Science Department, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Francisca Nwaokorie
- Department of Medical Laboratory Science, College of Medicine, University of Lagos, Lagos, Nigeria
| | - Omolola Titilayo Alade
- Department of Preventive and Community Dentistry, Faculty of Dentistry, Obafemi Awolowo University, Ile-Ife, Nigeria
| | - George Uchenna Eleje
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Effective Care Research Unit, Department of Obstetrics and Gynecology, Nnamdi Azikiwe University, Awka, Nigeria
| | - Joanne Lusher
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Provost's Group, Regent's University London, London, UK
| | - Morẹ Nikẹ Oluwátóyìn Foláyan
- Center for Reproduction and Population Health Studies, Oral Health Initiative, Nigerian Institute of Medical Research, Yaba, Lagos, Nigeria
- Department of Child Dental Health, Obafemi Awolowo University, Ile-Ife, Nigeria
| |
Collapse
|
5
|
Munabi IG, Adrian K, Mark M, Sylvia N, Kateete DP, Semitala FC, Mwaka E, Cameron JE, Buwembo W. Nanopore sequencing of non-oncogenic oral Papillomaviruses from people living with HIV. RESEARCH SQUARE 2025:rs.3.rs-6082806. [PMID: 40092439 PMCID: PMC11908340 DOI: 10.21203/rs.3.rs-6082806/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/19/2025]
Abstract
Objective To explore the diversity of non-oncogenic papillomaviruses in saliva samples from people living with HIV using nanopore amplicon-based sequencing for detection and typing. Methods This was a secondary analysis of data from the nanopore sequencing of amplicons obtained from polymerase chain reaction detection of papillomaviruses from 127 samples of people living with HIV. The sequencing data was cleaned and analyzed using a series of bash, Python and R scripts to produce output based on comparisons with the PAVE reference database for all known non-oncogenic papillomaviruses. Results A total of 171,194 reads corresponding to 201 known papillomavirus types were obtained from the data. Most of these reads (69%), belonged to the human non-oncogenic papillomavirus types. The most abundant nonhuman and non-oncogenic PV, Trichechus manatus latirostris papillomavirus 4 in 99% of the samples. There were nine other less abundant non-oncogenic papillomaviruses that were found in 95% or more of the samples as mixed infections. Conclusions This study demonstrates that there are many non-oncogenic PV infections in samples from PLHIV, most of which are mixed infections from this setting. It is important to note that the non-human non-oncogenic PVs, as a potential one health concern, were highly prevalent in this population.
Collapse
Affiliation(s)
- Ian G Munabi
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Kamulegeya Adrian
- Department of Dentistry, School of Dentistry, Makerere University College of Health Sciences, Kampala, Uganda
| | - Muwuluza Mark
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Nalwanga Sylvia
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - David P Kateete
- Department of Immunology & Molecular Biology, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | - Fred C Semitala
- Department of Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda
| | - Erisa Mwaka
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| | | | - William Buwembo
- Department of Anatomy, School of Biomedical Sciences, Makerere University College of Health Sciences, Kampala, Uganda
| |
Collapse
|
6
|
Morhason-Bello IO, Baisley K, Pavon MA, Adewole IF, Bakare R, Adebayo SA, de Sanjosé S, Francis SC, Watson-Jones D. Prevalence and concordance of penile, anal, and oral human papillomavirus infections among sexually active heterosexual men in Ibadan, Nigeria. Cancer Causes Control 2025; 36:51-66. [PMID: 39361165 DOI: 10.1007/s10552-024-01920-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2024] [Accepted: 09/16/2024] [Indexed: 10/06/2024]
Abstract
BACKGROUND The data on epidemiology of Human papillomavirus (HPV) infections in men are scarce relative to women generally, particularly among men engaging in heterosexual relationships. This study investigated the prevalence and risk factors for penile, anal, and oral HPV in men in two communities in Ibadan, Nigeria. METHODS This was a cross-sectional survey involving a face-to-face interview, a clinical examination, and sample collection from participants. HPV genotyping was performed with Anyplex II 28 HPV assay. The prevalences and factors associated with HPV infections using multivariable models and concordance between sites. RESULTS Of 316 men, the proportion of any HPV infection in the penile, anal, and oral sites was 40.5%, 9.7%, and 7.8%, respectively. The proportion of any high-risk HPV, low-risk HPV, and multiple HPV infections was highest in the penis followed by the anal and oral sites. Only 5/316 (1.6%) men had concordant HPV in all three sites, with the highest concordance in penile-anal sites relative to penile-oral and anal-oral sites. The odds of penile HPV were higher in men aged 25 years and above. Having penile HPV was associated with higher odds of detecting anal HPV and vice versa. Oral HPV was less likely in men not living with their sexual partners. CONCLUSION Penile HPV is the most common infection followed by anal HPV and oral HPV infections among heterosexual Nigerian men. Concordant HPV infections was highest in penile-anal sites. Nigerian men, as in other settings, are a reservoir of HPV and it is important to conduct more robust studies to appreciate their role in HPV transmission, epidemiology, and prevention.
Collapse
Affiliation(s)
- Imran O Morhason-Bello
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
- Institute of Advance Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria.
| | - Kathy Baisley
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
| | - Miquel Angel Pavon
- Infection and Cancer Laboratory, Cancer Epidemiology Research Program, ICO Barcelona, Spain, Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Bellvitge Biomedical Research Institute (IDIBELL), Gran Via de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, Barcelona, Spain
| | - Isaac F Adewole
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Oyo, Nigeria
| | - Rasheed Bakare
- Department of Microbiology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Sikiru A Adebayo
- Urological Division, Department of Surgery, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Silvia de Sanjosé
- Division of Cancer Epidemiology and Genetics, Medical Center Drive, National Cancer Institute, Rockville, Baltimore, MD, 9609, USA
- ISGlobal, Barcelona, Spain
| | - Suzanna C Francis
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
| | - Deborah Watson-Jones
- Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
| |
Collapse
|
7
|
Onwuamah CK, Feng N, Momoh AE, Uwandu M, Ahmed RA, Idigbe I, Vincent GD, Ogbu CA, Okonkwo N, Sokei J, Abimbola BS, Ojopagogo T, Okoli LC, Adesina M, Ezemelue PN, Sowunmi O, Okwuzu J, Labo−Popoola OH, Shaibu JO, Ohihoin GA, Nzeribe E, David A, Olaleye O, Ofotokun I, Dong X, Ezechi OC. Prevalence and risk factors for high-risk human papillomavirus infection among women from three southern geopolitical zones of Nigeria. Front Oncol 2023; 13:1254304. [PMID: 37876969 PMCID: PMC10593479 DOI: 10.3389/fonc.2023.1254304] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2023] [Accepted: 09/19/2023] [Indexed: 10/26/2023] Open
Abstract
Introduction Human Papillomavirus (HPV) infection is a risk factor for cervical cancer, the fourth most common cancer among women globally. Its burden is the highest in sub-Saharan Africa, with over 90% mortality. Interventions may fail without evidence-based data on stratified prevalence and risk factors among most at-risk women across Nigeria. Methods A cross-sectional comparative study, with participants recruited from the Nigerian Institute of Medical Research's Clinics, NGO outreaches, a cancer screening centre and a university teaching hospital. Questionnaires were self-administered. Trained medics performed sampling at healthcare facilities, and self-sampling was used at outreaches. Results Nine hundred eighty-five study participants were recruited. About 37% and 27% of the women knew about HPV and its vaccines, respectively, but only 6% confirmed vaccination with HPV vaccines. HPV prevalence was highest among women with unknown marital status (35.9%), single women (33.8%), widowed/divorced/separated women (30.3%), and married/cohabiting women (19.6%). HPV infection was significantly higher among women who take alcohol (odds=1.7 [95% CI: 1.2-2.4]) and women who smoke (odds=2.6 [95% CI: 1.4 - 4.6]. HPV strains detected included HPV16 (1.3%), HPV18 (1.5%), Low Risk (0.2%) and Other High-Risk groups (19.7%). Conclusion The inverse relationship between prevalence and education suggests interventions improving awareness and prevention would be impactful. Such interventions could also target HIV-positive women, women presenting with sexually-transmitted infections, who smoke and frequently drink alcohol.
Collapse
Affiliation(s)
- Chika Kingsley Onwuamah
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Ning Feng
- Center for Global Public Health, Chinese Centre for Disease Control and Prevention, Beijing, China
| | - Abidemi Esther Momoh
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Mabel Uwandu
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Rahaman Ademolu Ahmed
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
- Division of Allergy and Clinical Immunology, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, United States
| | - Ifeoma Idigbe
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| | - Grace Deborah Vincent
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Chinenye Angela Ogbu
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Nkem Okonkwo
- Department of Obstetrics and Gynaecology, Delta State University Teaching Hospital, Oghara, Delta, Nigeria
| | - Judith Sokei
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
- Department of Pediatric Oncology (Hematology), Washington University in St. Louis, St. Louis, MO, United States
| | - Bowofoluwa Sharon Abimbola
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Temiloluwa Ojopagogo
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Leona Chika Okoli
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Mary Adesina
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Priscilla Ngozi Ezemelue
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| | - Omowunmi Sowunmi
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Jane Okwuzu
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| | - Olaoniye Habeebat Labo−Popoola
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Joseph Ojonugwa Shaibu
- Centre for Human Virology and Genomics, Department of Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria
| | - Greg Aigbe Ohihoin
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| | - Emily Nzeribe
- Department of Obstetrics and Gynaecology, Federal Medical Centre, Owerri, Imo, Nigeria
| | - Agatha David
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| | - Olufemi Olaleye
- Screening Section, Optimal Cancer Care Foundation Centre, Lagos, Nigeria
| | - Ighovwerha Ofotokun
- Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, United States
| | - Xiao−ping Dong
- Center for Global Public Health, Chinese Centre for Disease Control and Prevention, Beijing, China
| | - Oliver Chukwujekwu Ezechi
- Centre for Reproduction and Population Health Studies, Department of Clinical Sciences, Nigeria Institute Medical Research, Lagos, Nigeria
| |
Collapse
|
8
|
Rodrigues LLS, Pilotto JH, Martinelli KG, Nicol AF, De Paula VS, Gheit T, Oliveira NSC, Silva-de-Jesus C, Sahasrabuddhe VV, Da Silva DM, Kast WM, Hardick J, Gaydos CA, Morgado MG. Diversity of Anal HPV and Non-HPV Sexually Transmitted Infections and Concordance with Genital Infections in HIV-Infected and HIV-Uninfected Women in the Tapajós Region, Amazon, Brazil. Viruses 2023; 15:1328. [PMID: 37376627 PMCID: PMC10302924 DOI: 10.3390/v15061328] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2023] [Revised: 05/30/2023] [Accepted: 06/02/2023] [Indexed: 06/29/2023] Open
Abstract
The aim of this study was to classify the diversity of anal HPV and non-HPV sexually transmitted infections (STIs) and compare the concordance between anal and genital infections in HIV-infected and uninfected women living in the Tapajós region, Amazon, Brazil. A cross-sectional study was performed with 112 HIV-uninfected and 41 HIV-infected nonindigenous women. Anal and cervical scrapings were collected and analyzed for HPV, Chlamydia trachomatis (CT), Neisseria gonorrheae (NG), Trichomonas vaginalis (TV), Mycoplasma genitalium (MG), and Human alphaherpesvirus 2 (HSV-2). The Kappa test evaluated the concordance between anal and genital infections. The overall prevalence of anal HPV infection was 31.3% in HIV-uninfected and 97.6% in HIV-infected women. The most frequent anal high-risk HPV (hrHPV) types were HPV18 and HPV16 in HIV-uninfected women and HPV51, HPV59, HPV31, and HPV58 in HIV-infected women. Anal HPV75 Betapapillomavirus was also identified. Anal non-HPV STIs were identified in 13.0% of all participants. The concordance analysis was fair for CT, MG, and HSV-2, almost perfect agreement for NG, moderate for HPV, and variable for the most frequent anal hrHPV types. Thus, a high prevalence of anal HPV infection with moderate and fair concordance between anal and genital HPV and non-HPV STIs was observed in our study.
Collapse
Affiliation(s)
- Luana Lorena Silva Rodrigues
- Programa de Pós-Graduação em Ciências da Saúde, Instituto de Saúde Coletiva, Universidade Federal do Oeste do Pará, Santarém 68135-110, Brazil
- Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil; (J.H.P.); (C.S.-d.-J.)
- Programa de Pós-Graduação em Medicina Tropical, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil
| | - José Henrique Pilotto
- Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil; (J.H.P.); (C.S.-d.-J.)
| | | | - Alcina F. Nicol
- Instituto Nacional de Infectologia Evandro Chagas, INI-FIOCRUZ, Rio de Janeiro 21040-360, Brazil;
| | - Vanessa Salete De Paula
- Laboratório de Virologia Molecular e Parasitologia, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil;
| | - Tarik Gheit
- International Agency for Research on Cancer, 69366 Lyon, France;
| | | | - Carlos Silva-de-Jesus
- Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil; (J.H.P.); (C.S.-d.-J.)
| | | | - Diane M. Da Silva
- Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 90033, USA; (D.M.D.S.); (W.M.K.)
- Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA
| | - W. Martin Kast
- Department of Obstetrics and Gynecology, University of Southern California, Los Angeles, CA 90033, USA; (D.M.D.S.); (W.M.K.)
- Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA 90089, USA
- Department of Molecular Microbiology and Immunology, University of Southern California, Los Angeles, CA 90089, USA
| | - Justin Hardick
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; (J.H.); (C.A.G.)
| | - Charlotte A. Gaydos
- Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA; (J.H.); (C.A.G.)
| | - Mariza Gonçalves Morgado
- Laboratório de AIDS e Imunologia Molecular, IOC-FIOCRUZ, Rio de Janeiro 21040-360, Brazil; (J.H.P.); (C.S.-d.-J.)
| |
Collapse
|
9
|
Uwamungu S, Nigussie B, Muvunyi CM, Hasséus B, Andersson M, Giglio D. Prevalence of Human Papillomavirus in Different Mucous Membranes in HIV Concordant Couples in Rwanda. Viruses 2023; 15:v15041005. [PMID: 37112984 PMCID: PMC10145982 DOI: 10.3390/v15041005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 04/13/2023] [Accepted: 04/14/2023] [Indexed: 04/29/2023] Open
Abstract
BACKGROUND The prevalence of human papillomavirus (HPV) infections in other anatomical sites besides the uterine cervix is unknown in East Africa. Here, we assessed the prevalence and concordance of HPVs in different anatomical sites in HIV concordant couples in Rwanda. METHODS Fifty HIV-positive concordant male-female couples at the HIV clinic at the University Teaching Hospital of Kigali in Rwanda were interviewed, swabbed from the oral cavity (OC), oropharynx (OP), anal canal (AC), vagina (V), uterine cervix (UC) and penis. A pap smear test and a self-collected vaginal swab (Vself) were taken. Twelve high-risk (HR)-HPVs were analyzed. RESULTS HR-HPVs occurred in 10%/12% in OC, 10%/0% in OP and 2%/24% in AC (p = 0.002) in men and women, respectively. HR-HPVs occurred in 24% of UC, 32% of Vself, 30% of V and 24% of P samples. Only 22.2% of all HR-HPV infections were shared by both partners (κ -0.34 ± 0.11; p = 0.004). The type-specific HR-HPV concordance was significant between male to female OC-OC (κ 0.56 ± 0.17), V-VSelf (κ 0.70 ± 0.10), UC-V (κ 0.54 ± 0.13), UC-Vself (κ 0.51 ± 0.13) and UC-female AC (κ 0.42 ± 0.15). CONCLUSIONS HPV infections are prevalent in HIV-positive couples in Rwanda but concordance within couples is low. Vaginal self-sampling for HPV is representative of cervical HPV status.
Collapse
Affiliation(s)
- Schifra Uwamungu
- Department of Pharmacology, Sahlgrenska Academy at the University of Gothenburg, SE-40530 Gothenburg, Sweden
- Department of Biomedical Laboratory Sciences, School of Health Sciences, College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 3286, Rwanda
| | - Bethelehem Nigussie
- Department of Pathology, Armauer Hansen Research Institute, Addis Ababa P.O. Box 1005, Ethiopia
| | - Claude Mambo Muvunyi
- Department of Clinical Biology, School of Medicine and Pharmacy, College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 3286, Rwanda
- Rwanda Biomedical Center, Kigali P.O. Box 7162, Rwanda
| | - Bengt Hasséus
- Department of Oral Medicine and Pathology, Institute of Odontology, Sahlgrenska Academy at the University of Gothenburg, P.O. Box 450, SE-40530 Gothenburg, Sweden
- Clinic of Oral Medicine, Public Dental Service, SE-40233 Gothenburg, Sweden
| | - Maria Andersson
- Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy at the University of Gothenburg, SE-40530 Gothenburg, Sweden
- Department of Clinical Microbiology, Sahlgrenska University Hospital, SE-41346 Gothenburg, Sweden
| | - Daniel Giglio
- Department of Pharmacology, Sahlgrenska Academy at the University of Gothenburg, SE-40530 Gothenburg, Sweden
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at the University of Gothenburg, SE-41345 Gothenburg, Sweden
- Department of Oncology, Sahlgrenska University Hospital, SE-41345 Gothenburg, Sweden
| |
Collapse
|
10
|
Minhas S, Kashif M, Rehman Z, Idrees M, Ansari F. Molecular characterization and risk factors of oral high-risk human papillomavirus among females in Punjab, Pakistan. J Med Virol 2023; 95:e27893. [PMID: 35644904 DOI: 10.1002/jmv.27893] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2022] [Revised: 05/14/2022] [Accepted: 05/26/2022] [Indexed: 01/11/2023]
Abstract
BACKGROUND The development of oral and oropharyngeal cancers is associated with human papillomavirus (HPV) infection. However, debate exists about the prevalence of high-risk oral HPV (HR-HPV) and its associated risk factors. This study evaluated the distribution of genotypes and associated risk factors of oral HR-HPV infection in the normal oral mucosa of the Pakistani female population with general gynecological problems. METHODS A total of 200 females from a regional gynecological hospital in Pakistan were included in this cross-sectional study. A self-administered questionnaire was carried out, followed by the study participants' oral and dental examinations. Whole saliva was collected by a drooling method. The viral DNA extraction and oral HR-HPV genotyping were detected via real-time polymerase chain reaction. RESULTS Among the 200 females (mean age, 37.76 years), 22 females (11%) were positive for oral HR-HPV DNA. Single oral HR-HPV infection was seen in 8%, whereas co-infection was observed in 3% with HPV16 and HPV18 most common genotypes. Comparison of the risk factors like oral sex history odds ratio (OR 8.21, 95% confidence interval [CI] 1.85-28.16; p < 0.005), and open-mouth kissing (OR, 5.17; 95% CI 1.48-27.41; p = 0.005) with oral HR-HPV infection was found to be significantly associated. CONCLUSION In Pakistan, oral HR-HPV-positive infection is not uncommon; HPV16 and HPV18 are the most frequent genotypes. Furthermore, this study also provides data that oral HR-HPV positive infection was significantly associated with sexual behaviors. Therefore, preventive health efforts, like health education and vaccination, should be practiced.
Collapse
Affiliation(s)
- Sadia Minhas
- Department of Microbiology, Institute of Molecular Biology & Biotechnology, The University of Lahore, Lahore, Pakistan
- Department of Oral Pathology, Dental Section, Akhtar Saeed Medical and Dental College, Lahore, Pakistan
| | - Muhammad Kashif
- Department of Oral Pathology, Bakhtawar Amin Medical and Dental College, Multan, Pakistan
| | - Zobaria Rehman
- Center of Applied Molecular Biology (CAMB), University of the Punjab, Lahore, Pakistan
| | - Muhammad Idrees
- Center of Excellence in Molecular Biology (CEMB), University of the Punjab, Lahore, Pakistan
| | - Farheen Ansari
- Department of Microbiology, Institute of Molecular Biology & Biotechnology, The University of Lahore, Lahore, Pakistan
| |
Collapse
|
11
|
Morhason-Bello IO, Baisley K, Pavon MA, Adewole IF, Bakare RA, de Sanjosé S, Francis SC, Watson-Jones D. Oral, genital and anal human papillomavirus infections among female sex workers in Ibadan, Nigeria. PLoS One 2022; 17:e0265269. [PMID: 35353833 PMCID: PMC8967011 DOI: 10.1371/journal.pone.0265269] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Accepted: 02/25/2022] [Indexed: 11/18/2022] Open
Abstract
BACKGROUND There are limited data on the epidemiology of HPV in different anatomical sites of female sex workers (FSW). We investigated the prevalence and concordance of cervical, vulval, oral and anal HPV among FSW in Ibadan, Nigeria. METHODS FSWs aged 18-45 years were enrolled in a cross-sectional survey. After interview and clinical examination, samples were collected from mouth, cervix, vulva and anus. HPV genotyping was done with Anyplex II 28HPV assay. Multivariable analyses were performed to explore associated risk factors and concordance of HPV infections across sites. RESULTS In total, 315 FSWs participated in the study with a mean age of 30-6.5 years. The prevalence of any HPV infection was 88% in the vulva, 84% in the cervix, 75% in the anus and 24% in the oral cavity. HPV 35 was the most prevalent and concordant high-risk type in the four sites. The risk factors for HPV infection by anatomic site varied. CONCLUSION This large study showed a high prevalence and concordance of HPV infections of cervical, vulval, oral and anal HPV among FSWs in Nigeria. The potential to acquire and transmit HPV is high in this population, and we highlighted the urgency to protect young women through HPV vaccination.
Collapse
Affiliation(s)
- Imran O. Morhason-Bello
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
- Institute of Advance Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - Kathy Baisley
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London United Kingdom
| | - Miquel A. Pavon
- Infection and Cancer Laboratory, Cancer Epidemiology Research Program, ICO, Bellvitge Biomedical Research Institute (IDIBELL), Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain
- Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain
| | - Isaac F. Adewole
- Obstetrics and Gynaecology Department, Faculty of Clinical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Rasheed A. Bakare
- Department of Microbiology, Faculty of Basic Medical Sciences, College of Medicine, University of Ibadan, Ibadan, Nigeria
| | - Silvia de Sanjosé
- Division of Cancer Epidemiology and Genetics (DCEG), Consultant, National Cancer Institute (NCI), National Institutes of Health (NIH), USA and Associate Researcher, ISGlobal, Barcelona, Spain
| | - Suzanna C. Francis
- International Statistics and Epidemiology Group, London School of Hygiene and Tropical Medicine, London, United Kingdom
| | - Deborah Watson-Jones
- Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom
- Mwanza Intervention Trials Unit, National Institute for Medical Research, Mwanza, Tanzania
| |
Collapse
|